4,409 Synopsys, Inc. $SNPS Shares Purchased by Schaper Benz & Wise Investment Counsel Inc. WI

Key Points

• Schaper Benz & Wise Investment Counsel more than doubled its Synopsys holdings in the third quarter, purchasing 4,409 additional shares for a total of 8,647 shares valued at approximately $3.76 million.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of about $570. Synopsys shares opened at $509.99, near their 52-week high of $539.48.
• Synopsys reported quarterly EPS of $3.91 versus the $3.67 consensus and revenue of $2.48 billion, up 42.4% year over year. The company also authorized a $1 billion share buyback, while recent insider selling may weigh on investor sentiment.

Schaper Benz & Wise Investment Counsel Inc. WI lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 104.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,647 shares of the semiconductor company's stock after purchasing an additional 4,409 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI's holdings in Synopsys were worth $3,761,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. BlackRock Inc. acquired a new position in Synopsys during the 2nd quarter worth about $7,228,099,000. State Street Corp increased its stake in shares of Synopsys by 0.3% in the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company's stock valued at $4,128,317,000 after buying an additional 28,532 shares during the period. Van ECK Associates Corp increased its stake in shares of Synopsys by 19.7% in the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company's stock valued at $1,542,175,000 after buying an additional 569,687 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Synopsys by 40.7% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company's stock worth $1,377,174,000 after acquiring an additional 892,736 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its position in shares of Synopsys by 39.5% during the second quarter. Assenagon Asset Management S.A. now owns 2,455,402 shares of the semiconductor company's stock worth $1,095,281,000 after acquiring an additional 695,146 shares during the last quarter. Institutional investors own 85.47% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. KeyCorp upped their target price on Synopsys from $600.00 to $605.00 and gave the company an "overweight" rating in a report on Thursday, October 1st. BNP Paribas Exane raised their price target on shares of Synopsys from $420.00 to $475.00 and gave the stock a "neutral" rating in a report on Thursday, October 1st. Zacks Research upgraded shares of Synopsys from a "hold" rating to a "strong-buy" rating in a research report on Friday, October 2nd. UBS Group set a $570.00 price target on shares of Synopsys in a research report on Thursday, August 27th. Finally, Sanford C. Bernstein began coverage on Synopsys in a report on Friday, September 25th. They set an "outperform" rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $570.04.

Synopsys Stock Up 2.5%

Shares of NASDAQ:SNPS opened at $509.99 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. Synopsys, Inc. has a 52-week low of $362.55 and a 52-week high of $539.48. The business's 50 day simple moving average is $419.94 and its two-hundred day simple moving average is $439.00. The firm has a market cap of $97.73 billion, a P/E ratio of 90.10, a PEG ratio of 2.03 and a beta of 1.21.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The firm had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the previous year, the company posted $3.39 earnings per share. The company's quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts forecast that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.

Synopsys declared that its board has authorized a share buyback plan on Monday, October 5th that authorizes the company to buy back $1.00 billion in outstanding shares. This repurchase authorization authorizes the semiconductor company to purchase up to 1.1% of its shares through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its shares are undervalued.

Insider Buying and Selling at Synopsys

In other news, insider Aart de Geus sold 25,000 shares of Synopsys stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the completion of the transaction, the insider directly owned 120,421 shares in the company, valued at $53,197,180.96. This trade represents a 17.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the business's stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the sale, the chief financial officer directly owned 22,717 shares of the company's stock, valued at approximately $11,358,500. The trade was a 28.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 102,559 shares of company stock valued at $44,607,141 over the last ninety days. 0.56% of the stock is currently owned by corporate insiders.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Bank of America reiterated a Buy rating and a $600 price target, citing Synopsys’ AI-driven growth prospects, its collaboration with OpenAI and support from the company’s share-repurchase program. Bank of America Synopsys rating
• Positive Sentiment: Synopsys’ chip-design software is becoming increasingly important as AI systems make semiconductors more complex. Nvidia’s $2 billion investment and planned agentic-AI design and verification workflows reinforce the company’s strategic position. Nvidia and Synopsys AI partnership
• Positive Sentiment: A multiyear agreement with Amazon reportedly valued at more than $1 billion highlights strong demand for Synopsys’ tools and Amazon’s expanding AI-chip ambitions. The company also authorized a $1 billion buyback, which could support earnings per share and signal management’s confidence in long-term value.
• Positive Sentiment: Recent fundamentals remain strong: quarterly EPS of $3.91 exceeded the $3.67 consensus, revenue reached $2.48 billion versus $2.44 billion expected, and revenue grew 42.4% year over year. Analysts maintain a generally favorable view, with a consensus “Moderate Buy” rating and an average target near $584.
• Neutral Sentiment: Synopsys is reportedly exploring potential work with Chinese AI laboratories on chip-design technology. The opportunity could expand its addressable market, but China-related export controls and geopolitical restrictions may limit the commercial benefit. Synopsys Chinese AI laboratory report
• Neutral Sentiment: Reported short interest was listed at zero shares, implying no meaningful short-position pressure; however, the figure conflicts with the article’s description of a significant increase and should be treated cautiously.
• Negative Sentiment: Insiders have recently sold shares, including Janet Lee’s 1,144-share sale worth approximately $575,000 and CFO Sudhindra Kankanwadi’s larger transactions. The sales do not establish a change in business outlook, but they may create a near-term sentiment overhang.
• Negative Sentiment: At roughly 89–90 times earnings, Synopsys is priced for substantial growth. Any slowdown in EDA demand, acquisition-related leverage or disappointment after future earnings could make the stock vulnerable despite strong operating results.

Synopsys Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.